Abstract
Testicular cancer is a rare malignancy, comprising only about 1% of all cancers in men. Significant advances have been made in recent years with a reduction in overall mortality. Cure of metastatic disease is dependent upon accurate clinical and surgical/pathological staging, appropriate use of tumour markers, intensive chemotherapy regimens and the correct timing of surgery to remove residual disease [1–4].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Einhorn LH, Donohue JP (1977) Cis-diammine di-chloroplatinum, vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87:293–298
Newlands ES, Begant RHJ, Bagshaw KD (1980) Further advances in the management of malignant teratoma of the testis and other sites. Lancet 1:948–951
Peckham MJ, Barrett A, Lias KH (1980) The treatment of metastatic germ cell testicular tumour with bleomycin, etoposide and cisplatin (BEP). Br J Cancer 47:613–619
Oliver RTD (1985) Testicular germ cell tumours—a model for a new approach to treatment of adult solid tumours. Postgrad Med J 61:123–131
DeWys WD, Green SB, William SD et al. (1985) Prediction of nodal involvement and of relapse after lymphadenectomy in early stage testicular cancer. In: Proceedings of the American Society of Clinical Oncology, p 134
Hoskin P, Dilly S, Easton D et al. (1986) Prognostic factors in stage I non-seminomatous germ-cell testicular tumours managed by orchiectomy and surveillance: implications for adjuvant chemotherapy. J Clin Oncol 4:1031–1036
Sher H, Bosl G, Gelier N et al. (1983) Impact of symptomatic intervals on prognosis of patients with Stage III testicular cancer. Urology 21:559–5 61
Medical Research Council Working Party on Testicular Tumours (1984) Prognostic factors in advanced non-seminomatous germ cell testicular tumours: results of a multicentre study. Lancet 1:8–11
Germa-Lluch JR, Begent RMJ, Bagshaw KD (1980) Tumour marker levels and prognosis in malignant teratoma of the testis. Br J Cancer 42:850–855
Peckham MJ, Barrett A, McElwain TJ, Hendry WF, Raghavan D (1981) Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors. Br J Urol 53:162–172
Garrera L, Debonniere C, Berigiron R, Cioppani F, Jofipouici JJ, Thomas JP (1970) Testicular tumour metastatic growth rate. Bull Soc Med-Chirurg Hopit Fond Sanit Armees 2:93–97
Oliver RTD, Highman WJ, Kellett MJ, Curling M, Dacie JE (1985) The value of fine needle aspiration cytology in the management of metastatic germ cell tumours. Br J Urol 57:200–203
Esposti PL (1979) Aspiration biopsy cytology, part 2. In: Zajicek J (ed) Monographs in clinical cytology. Karger, Basel, pp 113–123
Oliver RTD, Hope-Stone HF, Blandy JP (1983) A justification for the use of surveillance in the management of stage I germ cell tumours of the testis. J Urol 55:760–763
Oliver RTD (1985) Fertility of patients with germ cell tumours of the testis before and after treatment with platinum and etoposide containing combination chemotherapy regimens. In: Jones WG (ed), Germcell tumours II. Perga-mon, London, p 467 (Advances in biosciences, vol 55)
Greist A, Einhorn LH, Williams SD et al. (1984) Pathological findings at orchidectomy following chemotherapy for disseminated testicular cancer. J Clin Oncol 2:1025–1027
Pugh RCB (1976) Testicular tumours—the panel classification. Blackwell Scientific, Oxford, pp 267–270
Mostofi FK (1984) Tumour markers and pathology of testicular tumours. In: Progress and controversies in oncological urology. Alan R Liss, New York, pp 69–87
Ragavan D, Heyderman E, Monoghan P et al. (1981) Hypothesis: when is a seminoma not a seminoma. J Clin Pathol 34:123–128
Oliver RTD (1987) HLA phenotype and clinico pathological behaviour of germcell tumours—possible evidence for clonal evolution from seminomas to non-seminomas. Andrologica (in press)
Ulbright TM, Lochrer PJ, Roth LM, Einhorn LH (1984) The development of non germ cell malignancies within germ cell tumours. Cancer 54:1824–1833
Oliver RTD, Blandy JP, Hendry WF, Pryor JP, Williams JP, Hope-Stone HF (1983) Evaluation of radiotherapy and/or surgico-pathological staging after chemotherapy in the management of metastatic germ cell tumours. Br J Urol 55:764–768
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Scaletscky, R., Stephenson, C., Oliver, R.T.D., Highman, W.J., Kellett, M.J. (1988). The Value of Fine Needle Aspiration Cytology in the Management of Metastatic Germ Cell Tumours. In: Luciani, L., Piscioli, F. (eds) Aspiration Cytology in the Staging of Urological Cancer. Springer, London. https://doi.org/10.1007/978-1-4471-1452-9_38
Download citation
DOI: https://doi.org/10.1007/978-1-4471-1452-9_38
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1454-3
Online ISBN: 978-1-4471-1452-9
eBook Packages: Springer Book Archive